Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pharmaceutical Vaneck ETF (PPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 263,356,900
  • Market Capitalization, $K 263,357
  • Shares Outstanding, K 4,438
  • 36-Month Beta 0.93
  • Price/Book 3.18
  • Price/Earnings ttm 22.02
  • Annual Dividend & Yield 1.03 (1.73%)
  • Most Recent Dividend 0.235 on 10/01/18
  • Sectors:

    ETFs - Healthcare

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.23 +1.79%
on 12/10/18
63.25 -6.29%
on 11/13/18
-3.67 (-5.83%)
since 11/09/18
3-Month
58.23 +1.79%
on 12/10/18
64.90 -8.67%
on 10/03/18
-3.12 (-5.00%)
since 09/11/18
52-Week
54.56 +8.63%
on 04/02/18
64.90 -8.67%
on 10/03/18
+0.71 (+1.21%)
since 12/11/17

Most Recent Stories

More News
Beaten-Down Pharma ETFs to Buy Post Q3 Results

Despite strong results, the broad market sell-off took the sheen from the pharma ETFs over the past month. These funds have a Zacks ETF Rank #2 (Buy), suggesting solid entry point on beaten down prices....

XPH : 41.18 (+0.17%)
MRK : 77.11 (-0.40%)
JNJ : 146.50 (+0.85%)
IHE : 153.40 (+0.08%)
PJP : 66.84 (+0.18%)
PPH : 59.27 (-0.17%)
PFE : 44.01 (-0.88%)
BMY : 52.43 (-0.29%)
FTXH : 20.88 (+0.24%)
Beaten-Down Pharma ETFs to Buy Post Q3 Results

Despite strong results, the broad market sell-off took the sheen from the pharma ETFs over the past month. These funds have a Zacks ETF Rank #2 (Buy), suggesting solid entry point on beaten down prices....

XPH : 41.18 (+0.17%)
MRK : 77.11 (-0.40%)
JNJ : 146.50 (+0.85%)
IHE : 153.40 (+0.08%)
PJP : 66.84 (+0.18%)
PPH : 59.27 (-0.17%)
PFE : 44.01 (-0.88%)
BMY : 52.43 (-0.29%)
FTXH : 20.88 (+0.24%)
ETF Strategies for the Midterm Elections

Investors should focus on some strategies as to which sector should they take positions or which should be avoided if bipartisan government forms.

TAN : 20.11 (+0.05%)
PPA : 52.88 (-0.58%)
GII : 47.17 (+0.23%)
IHE : 153.40 (+0.08%)
XAR : 83.75 (-0.40%)
IGF : 41.13 (+0.61%)
PPH : 59.27 (-0.17%)
KBE : 39.87 (-0.94%)
XPH : 41.18 (+0.17%)
ITA : 183.94 (-0.45%)
PJP : 66.84 (+0.18%)
ICLN : 8.73 (unch)
KRE : 50.20 (-1.03%)
FTXH : 20.88 (+0.24%)
ETF Strategies for the Midterm Elections

Investors should focus on some strategies as to which sector should they take positions or which should be avoided if bipartisan government forms.

TAN : 20.11 (+0.05%)
PPA : 52.88 (-0.58%)
GII : 47.17 (+0.23%)
IHE : 153.40 (+0.08%)
XAR : 83.75 (-0.40%)
IGF : 41.13 (+0.61%)
PPH : 59.27 (-0.17%)
KBE : 39.87 (-0.94%)
XPH : 41.18 (+0.17%)
ITA : 183.94 (-0.45%)
PJP : 66.84 (+0.18%)
ICLN : 8.73 (unch)
KRE : 50.20 (-1.03%)
FTXH : 20.88 (+0.24%)
VanEck Launches ESPO, ETF Focused on Fast Growing Video Game and eSports Industry

VanEck today announced the launch of the VanEck Vectors(R) Video Gaming and eSports ETF (NYSE Arca: ESPO).

BBH : 118.85 (+0.25%)
PPH : 59.27 (-0.17%)
GNRX : 22.36 (-8.13%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

AZN : 38.66 (+0.65%)
PJP : 66.84 (+0.18%)
IHE : 153.40 (+0.08%)
PPH : 59.27 (-0.17%)
PFE : 44.01 (-0.88%)
BMY : 52.43 (-0.29%)
Announcing VanEck Vectors Equity ETFs' September 2018 Distributions

VanEck announced today its regular distributions per share for the VanEck Vectors(R) equity exchange-traded funds.

PPH : 59.27 (-0.17%)
Pharma & Biotech ETFs Soar on Trump's Drug Plan

Trump's drug plan went in favor of pharma and biotech companies, which caused these ETFs soaring.

XPH : 41.18 (+0.17%)
PBE : 50.26 (-0.59%)
SBIO : 31.84 (-0.22%)
PTH : 78.14 (+0.44%)
PJP : 66.84 (+0.18%)
IHE : 153.40 (+0.08%)
PPH : 59.27 (-0.17%)
GNRX : 22.36 (-8.13%)
PILL : 26.65 (+0.36%)
SPY : 264.13 (+0.02%)
FTXH : 20.88 (+0.24%)
Pharma & Biotech ETFs Soar on Trump's Drug Plan

Trump's drug plan went in favor of pharma and biotech companies, which caused these ETFs soaring.

XPH : 41.18 (+0.17%)
PBE : 50.26 (-0.59%)
SBIO : 31.84 (-0.22%)
PTH : 78.14 (+0.44%)
PJP : 66.84 (+0.18%)
IHE : 153.40 (+0.08%)
PPH : 59.27 (-0.17%)
GNRX : 22.36 (-8.13%)
PILL : 26.65 (+0.36%)
SPY : 264.13 (+0.02%)
FTXH : 20.88 (+0.24%)
Q1 Earnings Drag Pharma ETFs Down

Pharma ETFs saw terrible trading over the past month as mediocre results failed to boost confidence in the space, pushing many funds to 52-week lows.

XPH : 41.18 (+0.17%)
JNJ : 146.50 (+0.85%)
MRK : 77.11 (-0.40%)
PJP : 66.84 (+0.18%)
IHE : 153.40 (+0.08%)
LLY : 114.50 (+0.36%)
PPH : 59.27 (-0.17%)
PFE : 44.01 (-0.88%)
BMY : 52.43 (-0.29%)
FTXH : 20.88 (+0.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade PPH with:

Fund Summary

The VanEck Vectors Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical...

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 60.56
1st Resistance Point 59.92
Last Price 59.27
1st Support Level 58.74
2nd Support Level 58.20

See More

52-Week High 64.90
Fibonacci 61.8% 60.95
Fibonacci 50% 59.73
Last Price 59.27
Fibonacci 38.2% 58.51
52-Week Low 54.56

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar